Clinical impact of suboptimal RAASi therapy following an episode of hyperkalaemia

• Eiichiro Kanda (first author) presents an analysis of the AstraZeneca-sponsored ZORA study

published in BMC Nephrol earlier this year

• This 3-minute video and accompanying infographic reviews the patterns of guideline-

recommended RAASi target dose attainment following a hyperkalaemia episode and the

impact of RAASi down-titration or discontinuation on cardiorenal events in patients with

CKD or HF

• Stay tuned for additional assets on the ZORA study to be available later this year

Login

Need an account?

Country *

Preferred language *

Unfortunately, access to IMPACT Academy is not currently available for your country. Please register your details below and we will contact you when it becomes available.

Code Médecins *

Professional ID

RIZIV/INAMI *

PWZ Licence Number *

Healthcare Professional Code *

License Number *

Medical License Number (Specialty ID) *

Organization Name *

Mobile *

National Id

Email Address *

We are unable to continue the registration process due to your AstraZeneca email address. Please either use an alternative email address or use the AstraZeneca single sign-on access link here which is available for AstraZeneca users that have been approved access.

Medical Council ID (MMC ID)

Title

First Name *

Surname *

City

Place of Practice

Workplace *

Work address *

Workplace postal code *

Phone *

Cell Phone *

Phone Number *

Phone *

Phone number *

Phone *

Workplace postal code *

Organization *

Phone *

Password *

Confirm Password *

Select your Speciality *

Profession *

I verify that I'm a Healthcare Professional*

I agree to receive SMS communications from AstraZeneca about the IMPACT Academy**

I confirm the receipt of medical and marketing material from AstraZeneca Israel by email, text and/or other mailing. I agree that my details will be kept in the company's customer pool and used for the defined purposes in Privacy Policy. ***

I agree to receive email communications from AstraZeneca about the IMPACT Academy**

I agree to the OneKey Web Authentication *

To continue, please confirm that you accept our Terms and Conditions and have read and understood the Privacy Policy*

**You can opt-out at any time from your account page or by clicking the unsubscribe link on any emails that you receive from us

step 1
Final step